SCHEMBL13397683

SCHEMBL13397683

CN1C(=CC=CC=C(C#N)C(N)=O)Sc2ccccc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 10/20 0.50
▸ MEN1 O00255 6/20 0.50
▸ KMT2A Q03164 6/20 0.50
▸ CYP1A2 P05177 1/20 0.50
▸ CYP3A4 P08684 1/20 0.50
▸ CYP2C9 P11712 1/20 0.50
▸ CYP2C19 P33261 1/20 0.50
▸ MCL1 Q07820 2/20 0.46
▸ ALDH1A1 P00352 7/20 0.44
▸ HSD17B10 Q99714 2/20 0.44
▸ MAPT P10636 10/20 0.43
▸ NPC1 O15118 8/20 0.43
▸ L3MBTL1 Q9Y468 5/20 0.43
▸ KDM4E B2RXH2 3/20 0.43
▸ HPGD P15428 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ SMN1; SMN2 Q16637 6/20 0.43
▸ NFKB1 P19838 3/20 0.43
▸ NFKB2 Q00653 3/20 0.43
▸ RELA Q04206 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13889560 0.76 MAPT (0.52) RAB9AMEN1KMT2AALDH1A1HSD17B10
SCHEMBL14437578 0.75 MEN1 (0.58) RAB9AMEN1KMT2AALDH1A1HSD17B10
SCHEMBL24390187 0.75 FNTA (0.60) RAB9AMEN1KMT2ACYP3A4CYP2C9
SCHEMBL11318462 0.73 MAPT (0.37) RAB9AMEN1KMT2AALDH1A1HSD17B10
SCHEMBL11318458 0.73 MAPT (0.37) RAB9AMEN1KMT2AALDH1A1HSD17B10
SCHEMBL14437581 0.73 PDF (0.56) RAB9AMEN1KMT2ACYP2C9ALDH1A1
SCHEMBL24390191 0.71 FNTA (0.49) RAB9AMEN1KMT2AALDH1A1HSD17B10
SCHEMBL14435900 0.70 ALDH1A1 (0.48) RAB9AMEN1KMT2ACYP1A2CYP2C19
SCHEMBL10621158 0.69 ALDH1A1 (0.57) RAB9AMEN1KMT2ACYP1A2CYP2C19
SCHEMBL10621154 0.69 ALDH1A1 (0.57) RAB9AMEN1KMT2ACYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100104985-A1 COMPOUND FOR PHOTORESIST, PHOTORESIST LIQUID, AND ETCHING METHOD USING THE SAME FUJIFILM CORPORATION (JP) 2010-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100104985-A1 COMPOUND FOR PHOTORESIST, PHOTORESIST LIQUID, AND ETCHING METHOD USING THE SAME PYCR1, STK10, STK4 RAB9A 3683/4885MEN1 1278/4885KMT2A 1016/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback